UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
TriNet
TNET
$3.09B
| $1.55M | ﹤0.01% |
31,304
-83,410
| -73% | -$3.58M |
|
5302
Alto Neuroscience
ANRO
$1.19B
| $1.55M | ﹤0.01% |
58,697
+41,447
| +240% | +$958K |
|
|
BOT
5303
RoboStrategy Inc
BOT
$720M
| $1.55M | ﹤0.01% |
+38,956
| New | +$1.2M |
|
|
JFLX
5304
JPMorgan Flexible Debt ETF
JFLX
$1.53B
| $1.55M | ﹤0.01% |
30,663
+22,786
| +289% | +$1.14M |
|
5305
Palisade Bio
PALI
$277M
| $1.54M | ﹤0.01% |
737,307
-429,644
| -37% | -$846K |
|
5306
CALL
Oscar Health
OSCR
$9.92B
| $1.54M | ﹤0.01% |
54,000
-220,500
| -80% | -$4.75M |
|
5307
Arcos Dorados Holdings
ARCO
$1.59B
| $1.54M | ﹤0.01% |
190,608
-329,575
| -63% | -$2.85M |
|
5308
PUT
Fortinet
FTNT
$125B
| $1.54M | ﹤0.01% |
10,000
-1,000
| -9% | -$116K |
|
5309
Oil-Dri
ODC
$1.29B
| $1.53M | ﹤0.01% |
14,998
-14,791
| -50% | -$1.18M |
|
|
OPTU
5310
Optimum Communications Inc
OPTU
$412M
| $1.53M | ﹤0.01% |
1,054,580
+158,201
| +18% | +$197K |
|
5311
Invesco DB US Dollar Index Bearish Fund
UDN
$104M
| $1.53M | ﹤0.01% |
85,462
-56,804
| -40% | -$1.03M |
|
5312
Direxion Daily FTSE China Bull 3X ETF
YINN
$593M
| $1.53M | ﹤0.01% |
71,074
-12,586
| -15% | -$398K |
|
5313
PUT
CME Group
CME
$99.2B
| $1.52M | ﹤0.01% |
6,900
-79,100
| -92% | -$21.9M |
|
5314
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$456M
| $1.52M | ﹤0.01% |
64,822
+5,466
| +9% | +$128K |
|
5315
Invesco Global Listed Private Equity ETF
PSP
$228M
| $1.52M | ﹤0.01% |
27,335
+508
| +2% | +$30.2K |
|
5316
Mercantile Bank Corp
MBWM
$1.04B
| $1.52M | ﹤0.01% |
26,490
-9,149
| -26% | -$482K |
|
5317
Koppers
KOP
$857M
| $1.52M | ﹤0.01% |
33,822
+1,216
| +4% | +$49.8K |
|
|
BCV
5318
Bancroft Fund
BCV
$133M
| $1.52M | ﹤0.01% |
58,385
-2,488
| -4% | -$61.7K |
|
5319
Perspective Therapeutics
CATX
$329M
| $1.52M | ﹤0.01% |
444,917
-75,988
| -15% | -$287K |
|
|
MSTX
5320
Defiance Daily Target 2x Long MSTR ETF
MSTX
$369M
| $1.52M | ﹤0.01% |
203,798
+203,474
| +62,801% | +$5.12M |
|
5321
PUT
McCormick & Company Non-Voting
MKC
$13.1B
| $1.51M | ﹤0.01% |
+30,000
| New | +$1.47M |
|
5322
Karat Packaging
KRT
$994M
| $1.51M | ﹤0.01% |
45,103
+20,389
| +82% | +$587K |
|
5323
PUT
Caesars Entertainment
CZR
$6.04B
| $1.51M | ﹤0.01% |
50,000
-40,000
| -44% | -$1.13M |
|
|
SRTA
5324
Strata Critical Medical Inc
SRTA
$472M
| $1.5M | ﹤0.01% |
285,137
-8,456
| -3% | -$44.5K |
|
5325
Liberty All-Star Equity Fund
USA
$1.8B
| $1.5M | ﹤0.01% |
258,483
-99,157
| -28% | -$572K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.